Indium-111-Labeled Single-Domain Antibody for In Vivo CXCR4 Imaging Using Single-Photon Emission Computed Tomography., PMID:40067691
Focal Molography Allows for Affinity and Concentration Measurements of Proteins in Complex Matrices with High Accuracy., PMID:39996969
PET imaging of HIV-1 envelope protein gp120 using 18F-labeled nanobodies., PMID:39917021
Targeted degradation of the HPV oncoprotein E6 reduces tumor burden in cervical cancer., PMID:39464070
Highly potent and broadly neutralizing anti-CD4 trimeric nanobodies inhibit HIV-1 infection by inducing CD4 conformational alteration., PMID:39138183
Ultrapotent Broadly Neutralizing Human-llama Bispecific Antibodies against HIV-1., PMID:38704686
Novel bispecific nanobody mitigates experimental intestinal inflammation in mice by targeting TNF-α and IL-23p19 bioactivities., PMID:38533646
Methods for studying P2X4 receptor ion channels in immune cells., PMID:38311008
Microbiota-dependent activation of CD4+ T cells induces CTLA-4 blockade-associated colitis via Fcγ receptors., PMID:38175892
Neutrophil-Mediated Tumor-Targeting Delivery System of Oncolytic Bacteria Combined with ICB for Melanoma Lung Metastasis Therapy., PMID:37565362
Nanobody-mediated complement activation to kill HIV-infected cells., PMID:36799046
Bispecific antibody CAP256.J3LS targets V2-apex and CD4-binding sites with high breadth and potency., PMID:36729903
Structural basis for llama nanobody recognition and neutralization of HIV-1 at the CD4-binding site., PMID:35413243
Combination therapy with Nab-paclitaxel and the interleukin-15 fused with anti-human serum albumin nanobody as a synergistic treatment for colorectal cancer., PMID:35019820
Single-Domain Antibodies for Targeting, Detection, and In Vivo Imaging of Human CD4+ Cells., PMID:34956237
Improved targeting of human CD4+ T cells by nanobody-modified AAV2 gene therapy vectors., PMID:34928979
Cell membrane-anchored anti-HIV single-chain antibodies and bifunctional inhibitors targeting the gp41 fusion protein: new strategies for HIV gene therapy., PMID:34821542
Selective inhibition of IL-6 trans-signaling by a miniaturized, optimized chimeric soluble gp130 inhibits TH17 cell expansion., PMID:34404751
Therapeutic depletion of CCR8+ tumor-infiltrating regulatory T cells elicits antitumor immunity and synergizes with anti-PD-1 therapy., PMID:33589525
Generation of HIV-resistant cells with a single-domain antibody: implications for HIV-1 gene therapy., PMID:33462383
Anti-NKG2D single domain-based antibodies for the modulation of anti-tumor immune response., PMID:33457075
Labeling and tracking of immune cells in ex vivo human skin., PMID:33349704
The Potential of Nanobody-Targeted Photodynamic Therapy to Trigger Immune Responses., PMID:32326519
Super Potent Bispecific Llama VHH Antibodies Neutralize HIV via a Combination of gp41 and gp120 Epitopes., PMID:31544844
Domain swapping of complementarity-determining region in nanobodies produced by Pichia pastoris., PMID:31309388
The Antigenic Topology of Norovirus as Defined by B and T Cell Epitope Mapping: Implications for Universal Vaccines and Therapeutics., PMID:31083353
Peptide barcoding for establishment of new types of genotype-phenotype linkages., PMID:31013333
Novel fusion cells derived from tumor cells expressing the heterologous α-galactose epitope and dendritic cells effectively target cancer., PMID:30661833
In Vivo Blockade of Murine ARTC2.2 During Cell Preparation Preserves the Vitality and Function of Liver Tissue-Resident Memory T Cells., PMID:30038627
Nanobody-Antigen Conjugates Elicit HPV-Specific Antitumor Immune Responses., PMID:29792298
A defucosylated bispecific multivalent molecule exhibits broad HIV-1-neutralizing activity and enhanced antibody-dependent cellular cytotoxicity against reactivated HIV-1 latently infected cells., PMID:29762173
Intracellular immunization against HIV infection with an intracellular antibody that mimics HIV integrase binding to the cellular LEDGF protein., PMID:29203900
Selection of nanobodies with broad neutralizing potential against primary HIV-1 strains using soluble subtype C gp140 envelope trimers., PMID:28827559
Generation of Immunity against Pathogens via Single-Domain Antibody-Antigen Constructs., PMID:27821668
The Tax-Inducible Actin-Bundling Protein Fascin Is Crucial for Release and Cell-to-Cell Transmission of Human T-Cell Leukemia Virus Type 1 (HTLV-1)., PMID:27776189
The Glycosylphosphatidylinositol-Anchored Variable Region of Llama Heavy Chain-Only Antibody JM4 Efficiently Blocks both Cell-Free and T Cell-T Cell Transmission of Human Immunodeficiency Virus Type 1., PMID:27654286
Expression of Human Immunodeficiency Virus Type 1 Neutralizing Antibody Fragments Using Human Vaginal Lactobacillus., PMID:26950606
The transduction pattern of IL-12-encoding lentiviral vectors shapes the immunological outcome., PMID:26377033
CD4 binding site broadly neutralizing antibody selection of HIV-1 escape mutants., PMID:25762593
Neutralisation of HIV-1 cell-cell spread by human and llama antibodies., PMID:25700025
Rational design and characterization of the novel, broad and potent bispecific HIV-1 neutralizing antibody iMabm36., PMID:24853313
Specificities of human CD4+ T cell responses to an inactivated flavivirus vaccine and infection: correlation with structure and epitope prediction., PMID:24789782
Structural basis for the inhibition of HIV-1 Nef by a high-affinity binding single-domain antibody., PMID:24620746
Immunogenicity of targeted lentivectors., PMID:24519916
Exceptionally potent and broadly cross-reactive, bispecific multivalent HIV-1 inhibitors based on single human CD4 and antibody domains., PMID:24198429
Heavy chain-only IgG2b llama antibody effects near-pan HIV-1 neutralization by recognizing a CD4-induced epitope that includes elements of coreceptor- and CD4-binding sites., PMID:23843638
Straightforward selection of broadly neutralizing single-domain antibodies targeting the conserved CD4 and coreceptor binding sites of HIV-1 gp120., PMID:23152508
Single-domain antibody-SH3 fusions for efficient neutralization of HIV-1 Nef functions., PMID:22345475
Inhibition of the Nef regulatory protein of HIV-1 by a single-domain antibody., PMID:21292773
For research use only. Not for human or drug use.
